21 February 2020 MEDIA RELEASE
Bannister Law Investigation into Opioid Pain Treatments
Bannister Law Class Actions (BLCA) is investigating a potential class action against the makers and distributors of opioid pain treatment drugs in Australia.
Bannister Law is calling for consumers and concerned doctors who purchased or prescribed opioid treatment products such as OxyContin, OxyNorm or Fentanyl between 1 April 2014 and 20 January 2020 to register for a potential consumer class action below.
The purpose of a potential class action would be to seek compensation for consumers who purchased these medications and who suffered financial loss due to the addictive proclivity of these drugs.